Table 3.

Response, survival and local tumor progression rates for patients with 3.1-7.0 cm HCC after ME-RFA with SWC

	Tumor size
	Medium	Large	p value
	n=53	n=17
Complete response to ME-RFA SWC	79.3%	76.5%	0.749
PTE	91.4%	94.1%	1.000
Survival			0.909
2-year survival rates	84.6%	83.7%
3-year survival rates	80.8%	83.7%
Local tumor progression			0.476
1-year local tumor progression rates	8.6%	18.7%
2-year local tumor progression rates	16.7%	18.7%
	BCLC stage
	Stage A	Stage B1	Stage B2	p value
	n=30	n=25	n=15
Complete response to ME-RFA SWC	73.3%	80.0%	80.0%	0.806
PTE	90.0%	88.0%	100.0%	0.395
Survival
2-year survival rates	85.9%	83.1%	83.6%	0.994
3-year survival rates	79.8%	83.1%	83.6%
Local tumor progression				0.295
1-year local tumor progression rates	7.7%	13.3%	17.0%
2-year local tumor progression rates	13.5%	21.2%	27.4%